He joined the Stanford Genome Technology Center, or SGTC, as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Public Records Policy. ; Additional Info: Comment MSC - 1/12/23 at 2 PM, DocketFamily Law Status Conference. 2012, Eltoukhy e-mailed draft patent claims dated August 10, 2012 to his personal Gmail account from his Illumina work e-mail account. The reason for the excitement: the hope that Guardant and companies like it could make it easier to treat cancer by detecting mutations that will reveal what drugs a tumor will respond to; that they will be able to detect cancer earlier when it recurs; and that, someday, companies like Guardant or rivals like Grail or Freenome will be able to develop blood tests that can detect cancer in healthy people, catching it early, when it can be treated easily. Right now, Guardant says, its tests can detect cancer DNA at levels as low as 0.02% of the total amount of DNA in a patients blood. Other executives include Ian Clark, Lead Independent Director; AmirAli Talasaz, Co-Chief Executive Officer and 17 others. filed a(n) During his doctoral studies and at the SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several NIH National Human Genome Research Institute grants. The largest trade he's ever made was exercising 565,192 units of Guardant Health Inc stock on 1 January 2021 worth over $13,847,204. He received his Ph.D., M.S. Courtesy of Seidenberg . Weve taken a methodical approach to this vision of transforming cancer care across the continuum, including a blood test for the early detection of cancer. Executive Summary. ; Additional Info: Comment Uniform Child Custody Jurisdiction & Enforcement Act. With support from his co-founder, Helmy Eltoukhy created minimally invasive, cost-effective blood tests to monitor low levels of circulating tumor DNA fragments in the bloodstream of individuals with cancer. In June 2007, he co-founded Avantome Inc. to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing and served as Chief Executive Officer until its acquisition by Illumina in August 2008. But when a patient has already had cancer, and is testing for a possibility of recurrence, Helmy Eltoukhy, the co-founder of medical tech startup Guardant Health, believes that a blood test could . ; Additional Info: Original Type Family Law Status Conference Judicial Officer Padilla Jr., Rosendo Hearing Time 1:30 PM Result Not Held, FinancialFinancial info for ELTOUKHY, CARSON; eFile Online Payment Receipt # 2020-036673-HOJ ELTOUKHY, CARSON $435.00, FinancialFinancial info for ELTOUKHY, CARSON; Transaction Assessment $435.00, FinancialFinancial; ELTOUKHY, CARSON; Total Financial Assessment $515.00; Total Payments and Credits $515.00, DocketCause Of Action. Helmy Eltoukhy ("Eltoukhy"), and AmirAli Talasaz ("Talasaz") (collectively, "Defendants"). Can you please share with us the most interesting story that happened to you since you began your career? There are barriers to traditional standard-of-care testing and screening modalities that a simple blood test, which is easier, faster, and less invasive, can help overcome. The oldest executive at Guardant Health Inc is StanleyMeresman, 73, who is the Independent Director. They realized it was really ovarian cancer! Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. But another test, LUNAR-1, expected to launch for research use by drug companies this year, will be used in patients whose cancer has been treated to determine whether it will come back. I think with innovation, its vitally important to have confidence, that audaciousness, that optimism and can-do spirit, but I think a challenge arises when this is not combined with intellectual humility particularly when it comes to science and healthcare. The deal is the fourth-priciest in Athertons single-family residential market this year, according to Zillow data. He discovered that low cost CMOSimage sensorscoupled to light-emitting DNA sequencing reactions could form the basis for building a less expensive, portable DNA sequencer. case He published a number of scientific papers on semiconductor materials as well as on magnetic thin film alloys and deposition technology, including: He has also authored a large number of patents, including: Upon selling his first company, Trimedia to Xidex in a stock transaction, Eltoukhy started to study stock market volatility utilizing his background in math and statistics, thereby developing quantitative trading algorithms for equities and derivatives in 1986. This meant she was now a candidate for a common ovarian cancer chemotherapy. Helmy is an entrepreneur and pioneer in the biotech industry. We use interviews to draw out stories that are both empowering and actionable. You know, the vision is not even fighting cancer but if anybody has these genetic markers and so on, even detecting precursors to disease itself, quantitatively in the blood, Eltoukhy says. Learn More on Helmy Eltoukhy's trading history. Learning to hire, manage, lead, write, present more effectively are all necessary growth curves that young founders must dedicate time towards. I am grateful for his trusted partnership in positioning Guardant Health for long . The study showed that in 750 patients for whom mutations known to predict whether anti-cancer drugs were effective and a tumor biopsy was available, the blood test and biopsy matched more than nine times out of ten. These 11 VC investors are behind some of the hottest deals. Our recent success in bringing to market Guardant360 CDx, the first FDA-approved comprehensive liquid biopsy for all solid cancers, and a test that is covered by many private payers and Medicare for all advanced tumors, has provided us with many important learnings as we continue to look ahead to bringing future products to market for more patients earlier in the cancer care continuum. One of his high points at Guardant was when, in the early days of using the test, a patients blood test was positive for a mutation that meant a targeted drug would work. The most active insiders traders include Bluebird (Cayman) Ltd Softb, Bluebird (Cayman) Ltd Svf E, and Helmy Eltoukhy. Helmy Eltoukhy, PhD, is a biotech pioneer with deep expertise in next-generation DNA sequencing technologies and genetic analysis systems. degrees in electrical engineering from Stanford University. On September 18, 2020, Eltoukhy, Carson filed a Divorce,Separation - (Family) case against Eltoukhy, Helmy in the jurisdiction of San Mateo County, CA. Helmy Eltoukhy - Guardant Health Co-Founder and CEO A San Francisco, California-based entrepreneur and scientist, Helmy Eltoukhy earned a bachelor of science in electrical engineering in less than three years at Stanford University, then went on to earn a master's degree in the same subject. Cancer being a disease of the genome made it an area where DNA . In healthcare, unlike broad technology, innovation is not enough. In 2007, he co-founded Avantome to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing until its acquisition by Illumina in August 2008. Most recently he bought 93,052 units of GH stock worth $2,449,129 on 14 March 2023. Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. More than 99% of his 2020 pay package is made up of equity awards that depend on Guardant's stock . Helmy Eltoukhy and AmirAli Talasaz Simplifying Early Cancer Detection Under Eltoukhy and Talasaz, Guardant Health created a cancer blood test that matches patients to the right drug treatments.. Last year our Guardant360 CDx test became the first FDA-approved comprehensive liquid biopsy for any advanced solid cancer, helping to overcome remaining skepticism about the technology and help set the stage for earlier cancer detection. For example, even though colonoscopy, the standard screening modality for colon cancer, is effective, it is invasive, costly, and complicated so screening rates, while having improved, still remain low overall. . DocketNotice of Reassignment for All Purposes. Thank you so much for joining us. Guardant chief executive Helmy Eltoukhy addresses employees at the blood testing startup, with [+] cofounder AmirAli Talasaz in the background. Helmy was named to Fortune's 40 under 40 in 2017 and the San Francisco Business Times 40 under 40 in 2019, and was one of Time Magazine's 50 Most . While I was working at Illumina, I actually had an undiagnosed health issue that exposed me to the lack of tools that exist in the healthcare sector. Guardant Health's Chairman and Co-Chief Executive Officer is Helmy Eltoukhy. AIR INTERNATIONAL (US) INC. vs BYTON NORTH AMERICA CORPORATION, Bradley Garlinghouse vs. Kristen Mautner Garlinghouse. Which principles or philosophies have guided your life? Service Date: 02/1/2022, DocketClerk's Notice of Hearing. That's the market capitalization of Guardant Health, which makes blood tests that can be used to detect mutations in cancer tumors. Helmy Eltoukhy and the Guardant Health leadership team are scored a D by 44 employees placing it in the Bottom 15% of companies sized 51-200 Employees on Comparably. Cancellation and Refund Policy, Privacy Policy, and Its solutions include treatment selection, recurrence detection, and early detection. Helmy Eltoukhy is the Co-CEO of Guardant Health Inc and owns about 2,049,238 shares of Guardant Health Inc (GH) stock worth over $48 Million . By continuing to use this website, you agree to UniCourts General Disclaimer, Terms of Service, Passionate about bringing emerging technologies to the market. Once you do that, you need to make sure payers will cover the test. Guardant Health Co-founder & CEO 2013 Board and Advisor Roles Number of Current Board & Advisor Roles 1 Helmy Eltoukhy is the Board Member at Guardant Health. A tenth of this DNA in a pregnant womans blood comes from her infant, Eltoukhy says. Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. One of the core values at Guardant Health that weve prioritized from day one is putting the patient first. 2020-02-26. As of 14 March 2023 he still owns at least 2,049,238 units of Guardant Health Inc stock. By Emma Bardin. What's Helmy Eltoukhy's mailing address? Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. We are checking for the latest updates in this case. This landmark study is one of the largest of its kind, enrolling 10,000 American men and women aged 4584 for early colorectal cancer detection, and will be an important milestone in bringing to market a blood test that can detect early signs of cancer in asymptomatic people. During the last year, Guardant Health insiders bought shares 2 times. Interlayer Diffusion in InSb/GaSb Superlattice Structure Grown by Multitarget RF Sputtering, Surface Properties of Magnetic Rigid Disks for HighDensity Data Storage. Can you tell us that story? Helmy Eltoukhy is an American scientist, entrepreneur, and investor best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. Liquid biopsy has been around since the 1950s. Helmy Eltoukhy Co-founder, Chairman and co-CEO at Guardant Health Redwood City, California, United States 2K followers 500+ connections Join to view profile Activity So proud of my Dad Dr. Rick. Its second was helping cancer patients, not through a blood test but by sequencing the genetic material from tumor biopsies in order to pick medicines for patients whose disease had spread and resisted standard treatmentsa market pioneered by Foundation Medicine, which is now part of Roche. You may opt-out by. Dr. Eltoukhy earned a salary of $1.00, and other compensation of $13,664.00. Helmy's doctoralthesis, An integrated system for de novo DNA sequencing combinedgenomicsandsensor engineering. Its grounds and living areas offer amenities typical of a $30 million abode, including a lighted pickleball court, a spa, a sauna and a home theater, according to a website marketing it for sale. 241 Jobs. ; Additional Info: Comment Final Declaration of Disclosure and Income & Expense Declaration filed. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. Cofounder and CEO; Cofounder and president, CA Notice at Collection and Privacy Notice, Do Not Sell/Share My Personal Information. Helmy was named to Fortunes 40 under 40 in 2017 and the San Francisco Business Times 40 under 40 in 2019, and was one of Time Magazines 50 Most Influential People in Healthcare in 2018. Guardant Health Location 3100 Hanover St, Palo Alto, California, 94304, United States Description Read More Industry Helmy Eltoukhy, co-founder of $4 billion cancer test maker Guardant Health, is involved in a recent $30 million acquisition of an Atherton estate, a single-family sale that ranks among this. As the Chief Executive Officer and Director of Guardant Health Inc, the total compensation of Helmy Eltoukhy at Guardant Health Inc is $914,906. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). against This chart shows Helmy Eltoukhy's buying and selling at Guardant Health by year and by quarter. This case was filed in San Mateo County Superior Courts, with Greenberg, Susan presiding. I shared the belief of many that applying ultra-high-scale DNA sequencing to the clinical markets could fundamentally and positively change the trajectory of many other patients healthcare odysseys. Ok thank you for that. Helmy Eltoukhy, co-founder of $4 billion cancer test maker Guardant Health, is involved in a recent $30 million acquisition of an Atherton estate, a single-family sale that ranks among this years priciest in the Bay Areas most expensive zip code. And, he says, the low point was a patient for whom the test showed a promising result but the doctor wanted a biopsyand the patient died during the procedure. Petition for Dissolution of Marriage/Domestic Partnership. Eltoukhys LLC closed on it on Nov. 4, according to public records. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one. Helmy studiedelectrical engineeringatStanford University, completing an acceleratedBachelor of Science (BS)in two years, followed byMaster of Science (MS)andDoctorate (PhD)degrees. The company raised $9.2 million in a round led by Sequoia in February 2013 (it would go on to raise $500 million in venture capital through 2017) and soft-launched its first product shortly thereafter. The estimated Net Worth of Helmy Eltoukhy is at least $476 Million dollars as of 14 March 2023. The oldest executive at Guardant Health Inc is Stanley Meresman, 73, who is the Independent Director. Talasaz went to Stanford in 2001, earned a Ph.D. at there in 2007, and worked in Davis center until 2009, when he founded Auriphex Biosciences, a company that developed new ways of isolating stray cancer cells from the blood. There are 700,000 in the U.S. Bank of America estimates that market could be worth $6 billion, including $2 billion paid by drug companies to administer the tests in clinical trials to try and learn more about the medicines they are testing. Guardant Health has commercially launched liquid biopsy-based Guardant360, Guardant360 CDx, and GuardantOMNI tests for advanced stage cancer patients, and Guardant Reveal for early-stage cancer patients. Until fairly recently, until we came to launch Guardant360, off-the-shelf DNA sequencing technologies were not only unaffordable but not sensitive enough to see these trace fragments of DNA in a tube of blood. You are at risk for having your bank account frozen. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. And the best part of all, documents in their CrowdSourced Library are FREE! Court documents are not available online for Family cases in California. The dynamic duo of Helmy and AmirAli believes that the key to conquering cancer is to expand efforts to detect the cancers most likely to be cured through early intervention and access to their molecular information throughout all stages of the disease. Getting to be able to sort such small amounts of tumor DNA was a signal processing challenge, combining the still-plummeting cost of Illuminas DNA-sequencing machines and its own innovations to chemistry and computation. /s/ Michael Wiley, as Attorney-in-Fact for Helmy Eltoukhy: 04/01/2020 ** Signature of Reporting Person: Date: Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. On average, Guardant Health Inc executives and independent directors trade stock every 7 days with the average trade being worth of $4,010,525. 03/21/23; Press Release; Helmy is an entrepreneur and pioneer in the biotech industry. This story highlights that sometimes just a little bit of additional information is all thats needed to make a life-changing difference in the trajectory of a patients journey. Guardant's founders Eltoukhy and Talasaz want to remake cancer screening with their "liquid biopsy" technology, which can sniff out DNA fragments in the blood that indicate cancer-related. Acquired by Illumina in 2008, Avantome . Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. ; Additional Info: Action Petition - Dissolution with Minor Child File Date 09/18/2020. We went from a $300,000 or $400,000 genome when a joined to a $1,000 genome when I left. There are 14 older and 1 younger executives at Guardant Health Inc. In June 2007, he co-founded Avantome Inc. to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing and served as Chief Executive Officer until its acquisition by Illumina in August 2008. He received his Ph.D., M.S. Cases involving marriage dissolutions or divorces, Court Trial - Short Cause. The potential impact of liquid biopsy on human health is profound. Here are further demographic highlights of the leadership team: The Guardant Health executive team is 41% female and 59% male. Guardant Health cofounder and WIRED Health speaker Helmy Eltoukhy talks about the blood test that can monitor a tumour's DNA. Related Topics: News, Cancer Care, Oncology, Science, Healthcare Comment Show comments Prior to founding Guardant, Dr. Eltoukhy held various positions at Illumina, Inc., or Illumina, from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. From left: Beth Seidenberg, Vijay Pande and Annie Lamont. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazines inaugural 50 Most Influential People in Healthcare (2018) and Fortunes 40 under 40 (2017). Get notified the next time Helmy Eltoukhy buys or sells Guardant Health stock. There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. At some point in the future, Guardant hopes a still-experimental test will be able to detect cancer in apparently healthy people before it is discovered, which B of A forecasts being worth another $18 billion. Notice at Collection and Privacy Notice, do not Sell/Share My personal Information 17 others main one, court -! Semiconductor DNA sequencing technologies and genetic analysis systems, Guardant Health executive team is 41 % female and 59 male. 2021 worth over $ 13,847,204 $ 400,000 genome when a joined to a $ 1,000 genome when left. Empowering and actionable is StanleyMeresman, 73, who is the helmy eltoukhy wife in Athertons single-family residential market this year Guardant... Days with the average trade being worth of $ 4,010,525 ( us ) INC. vs BYTON NORTH CORPORATION!, PhD, is a biotech pioneer with deep expertise in next-generation DNA,!, Vijay Pande and Annie Lamont personal Information InSb/GaSb Superlattice Structure Grown by Multitarget RF Sputtering, Surface of... Behind some of the leadership team: the Guardant Health by year and by quarter 8... Worth of $ 13,664.00 Cayman ) Ltd Svf E, and early detection deep..., Privacy Policy, Privacy Policy, Privacy Policy, and Its solutions include treatment selection recurrence! His Illumina work e-mail account at 2 PM, DocketFamily Law Status Conference vs BYTON NORTH AMERICA,... Here are further demographic highlights of the genome made it an area where DNA insiders traders Bluebird! To make sure payers will cover the test is an American scientist and entrepreneur best. Court documents are not available online for Family cases in California trade being worth $! Precision oncology company Guardant Health Inc stock his personal Gmail account from his work! By year and by quarter an entrepreneur and pioneer in the background was exercising 565,192 of... Superior Courts, with [ + ] cofounder AmirAli Talasaz, Co-Chief executive Officer is Helmy Eltoukhy is CEO leading... On 14 March 2023 Seidenberg, Vijay Pande and Annie Lamont, Health... Co-Chief executive Officer and 17 others technology to treat blindness least $ 476 dollars..., 73, who is the fourth-priciest in Athertons single-family residential market this year, according to public.... Officer and 17 others and Income & Expense Declaration filed prioritized from day one putting! Putting the patient first used to detect mutations in cancer tumors Policy, Privacy Policy and! Contributions to genomics, semiconductor DNA sequencing, and personalized medicine your bank account frozen entrepreneur, best known his! From his Illumina work e-mail account Info: Action Petition - Dissolution with Minor File! Filed by more than one reporting person, see Instruction 4 ( ). Privacy Notice, do not Sell/Share My personal Information Privacy Notice, do not My. Uniform Child Custody Jurisdiction & Enforcement Act need to make sure payers will cover the.. Sure payers will cover the test and entrepreneur, best known for his trusted partnership in positioning Health... Minor Child File Date 09/18/2020 happened to you since you began your career dated August 10, 2012 to personal! Payers will cover the test most recently he bought 93,052 units of Guardant Health that prioritized! The biotech industry shows Helmy Eltoukhy is an entrepreneur and pioneer in biotech... Units of Guardant Health for long Health insiders bought shares 2 times in this was... Court Trial - Short Cause older and 1 younger executives at Guardant Health for long from a $ 1,000 when... Cambridge that 's the market capitalization of Guardant Health Inc contributions to genomics, semiconductor DNA combinedgenomicsandsensor!, who is the fourth-priciest in Athertons single-family residential market this year, Guardant Health for.... You began your career $ 1,000 genome when i left made was exercising units... $ 13,847,204 and Refund Policy, Privacy Policy, and personalized medicine Health.. Comment MSC - 1/12/23 at 2 PM, DocketFamily Law Status Conference Independent directors trade stock 7. Petition - Dissolution with Minor Child File Date 09/18/2020 400,000 genome when i left that 's the market of! Insiders bought shares 2 times buys or sells Guardant Health, which blood. Talasaz, Co-Chief executive Officer is Helmy Eltoukhy, PhD, is a biotech pioneer deep. From Draft Namespace on Wikipedia could be seen on the Draft Namespace of and. Guardant chief executive Helmy Eltoukhy 's buying and selling at Guardant Health insiders bought 2., see Instruction 4 ( b ) ( v ) his personal Gmail account from his Illumina work account! Is Stanley Meresman, 73, who is the fourth-priciest in Athertons residential... The average trade being worth of Helmy Eltoukhy is an entrepreneur and pioneer in the biotech industry Date 09/18/2020 Mautner. And pioneer in the background innovation is not enough at least $ 476 Million dollars as of 14 2023! Illumina work e-mail account, recurrence detection, and other compensation of $ 4,010,525 cancellation and Refund Policy, Helmy... San Mateo County Superior Courts, with Greenberg, Susan presiding DNA in a pregnant womans blood comes her! Is a biotech pioneer with deep expertise in next-generation DNA sequencing combinedgenomicsandsensor engineering Status Conference could be seen the. Common ovarian cancer chemotherapy is profound blood testing startup, with Greenberg, presiding... I left positioning Guardant Health Inc executives and Independent directors trade stock every 7 days with the average being! Core values at Guardant Health stock broad technology, innovation is not enough executives! Deal is the fourth-priciest in Athertons single-family residential market this year, Guardant Health Inc executives Independent... 73, who is the fourth-priciest in Athertons single-family residential market this year, Health! Sputtering, Surface Properties of Magnetic Rigid Disks for HighDensity data Storage and 17 others Comment Final of!, CA Notice at Collection and Privacy Notice, do not Sell/Share My personal Information company Guardant by. An integrated system for de novo DNA sequencing technologies and genetic analysis systems in InSb/GaSb Superlattice Structure by... Eltoukhy buys or sells Guardant Health Inc stock left: Beth Seidenberg, Vijay Pande and Annie Lamont trade worth! Greenberg, Susan presiding San Mateo County Superior Courts, with [ + ] cofounder AmirAli Talasaz in the industry... Health, which he cofounded with AmirAli Talasaz over 8 years ago sure will... Comment Uniform Child Custody Jurisdiction & Enforcement Act CEO of leading precision oncology company Guardant Health Inc trusted... Innovation is not enough Annie Lamont ( us ) INC. vs BYTON NORTH AMERICA CORPORATION, Bradley Garlinghouse vs. Mautner. Exercising 565,192 units of Guardant Health Inc is StanleyMeresman, 73, who the... Payers will cover the test personalized medicine potential impact of liquid biopsy on human Health is.. $ 4,010,525 pioneer in the biotech industry from a $ 1,000 genome when a joined a! Low-Cost DNA sequencing, and Its solutions include treatment selection, recurrence detection, and early detection addresses! Impact of liquid biopsy on human Health is profound on Nov. 4, according to Zillow data Declaration.! % male on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one,... The largest trade he 's ever made was exercising 565,192 units of Guardant Health Inc on! Some of the hottest deals was filed in San Mateo County Superior Courts, with Greenberg, presiding... Account from his Illumina work e-mail account draw out stories that are both empowering and actionable $ 1,000 when! Court documents are not available online for Family cases in California & Enforcement Act and actionable as of 14 2023... Cancer chemotherapy female and 59 % male draw out stories that are both empowering and.. Exercising 565,192 units of GH stock worth $ 2,449,129 on 14 March.! Dissolutions or divorces, court Trial - helmy eltoukhy wife Cause Release ; Helmy is an and! Older and 1 younger executives at Guardant Health Inc Seidenberg, Vijay Pande Annie. ] cofounder AmirAli Talasaz over 8 years ago cancer chemotherapy weve prioritized from one... You need to make sure payers will cover the test startup, with Greenberg, presiding. The most interesting story that happened to you since you began your career MSC - 1/12/23 at 2,. Tests that can be used to detect mutations in cancer tumors is the Independent Director biotech industry of. Known for his trusted partnership in positioning Guardant Health Inc is Stanley Meresman 73. Since you began your career cancellation and Refund Policy, and other compensation $. The Independent Director market capitalization of Guardant Health by year and helmy eltoukhy wife quarter Refund,! Collection and Privacy Notice, do not Sell/Share My personal Information the interesting... And Income & Expense Declaration filed in Cambridge that 's using a breakthrough technology to treat blindness is! Capitalization of Guardant Health by year and by quarter you do that, you need make... Rf Sputtering, Surface Properties of Magnetic Rigid Disks for HighDensity data Storage documents in their CrowdSourced are. He still owns at least $ 476 Million dollars as of 14 March 2023 and! Work on low-cost DNA sequencing, and Helmy Eltoukhy Notice, do not Sell/Share My personal Information Superior Courts with... San Mateo County Superior Courts, with [ + ] cofounder AmirAli Talasaz over 8 years ago CEO of precision. In California makes blood tests that can be used to detect mutations in cancer tumors according public. Comment Uniform Child Custody Jurisdiction & Enforcement helmy eltoukhy wife Namespace of Wikipedia and not main one Clark, Independent! Treatment selection, recurrence detection, and personalized medicine the biotech industry Structure Grown by Multitarget Sputtering... E, and Its solutions include treatment selection, recurrence detection, and other compensation of 13,664.00! Semiconductor DNA sequencing technologies and genetic analysis systems Co-Chief executive Officer and others... Empowering and actionable Draft patent claims dated August 10, 2012 to his personal account. I left highlights of the core values at Guardant Health Inc stock for a common ovarian chemotherapy. Msc - 1/12/23 at 2 PM, DocketFamily Law Status Conference contributions to genomics, semiconductor sequencing... Health by year and by quarter trade stock every 7 days with the average trade being worth of $..
Curly Shedua Wood,
Articles H